Get Your Free GLP-1 Information Guide

What GLP-1 Medications Are and How They Work

GLP-1 refers to glucagon-like peptide-1, a natural hormone your body produces that helps manage blood sugar levels. GLP-1 receptor agonist medications are drugs designed to work like this hormone. These medications were originally developed to treat type 2 diabetes, but doctors have increasingly prescribed them for weight management in recent years.

According to the American Diabetes Association, GLP-1 medications work by several mechanisms. They slow down how fast your stomach empties food into your small intestine, which means you feel fuller for longer. They also signal to your brain that you are satisfied, reducing hunger signals. Additionally, these medications help your pancreas release insulin when blood sugar levels rise, bringing those levels back to normal.

The most commonly known GLP-1 medications include semaglutide (brand names Ozempic for diabetes and Wegovy for weight management) and tirzepatide (Mounjaro for diabetes and Zepbound for weight management). Other options in this medication class include dulaglutide, liraglutide, and others. Each medication has its own dosing schedule, ranging from once-weekly injections to daily oral tablets, depending on which specific drug your doctor considers.

Research shows these medications can help people lose weight or manage blood sugar more effectively than diet and exercise alone. A 2023 study published in the New England Journal of Medicine found that people taking semaglutide for weight management lost an average of 15-22% of their body weight over 68 weeks, compared to about 2% for those receiving a placebo. However, results vary from person to person based on individual health factors, lifestyle, and other medications.

Understanding how these medications function helps you have informed conversations with your healthcare provider. The guide provides information about the biological mechanisms, which can help you understand why your doctor might recommend this type of medication and what realistic expectations might be.

Practical Takeaway: GLP-1 medications work by affecting how your body processes food, manages hunger, and controls blood sugar. Knowing this foundation helps you understand why doctors prescribe them and what happens in your body when you take them.

Medical Conditions That GLP-1 Medications May Address

GLP-1 medications have been approved by the FDA for specific medical purposes. The primary indication is type 2 diabetes management. Type 2 diabetes affects approximately 37 million Americans according to the CDC, and it occurs when your body cannot use insulin effectively or does not produce enough insulin. Multiple GLP-1 medications are approved specifically for improving blood sugar control in people with type 2 diabetes.

Beyond diabetes, GLP-1 medications have received FDA approval for weight management in people with obesity or who are overweight with weight-related health conditions. According to the CDC, more than 40% of American adults have obesity, defined as a BMI of 30 or higher. The FDA approved semaglutide (Wegovy) for weight management in 2021, and tirzepatide (Zepbound) in 2023. These approvals were based on clinical trials showing significant weight loss results.

There is ongoing research into other potential uses for GLP-1 medications. Some studies suggest they may help with cardiovascular health outcomes, particularly in people with diabetes and heart disease. The LEADER trial and SUSTAIN-6 trial, published in major medical journals, showed cardiovascular benefits for certain GLP-1 medications. However, it is important to note that not all GLP-1 medications have the same studied benefits, and research is continuing in this area.

Some healthcare providers have begun prescribing GLP-1 medications off-label for conditions other than their FDA approvals, though this is a decision between you and your doctor based on medical literature and your individual situation. Off-label use means a medication approved for one condition is used for another condition. This is legal and sometimes appropriate, but it means the medication has not undergone FDA approval testing specifically for that use.

A free information guide about GLP-1 medications typically includes details about these various conditions, the research supporting use for each condition, and information about how healthcare providers decide which medication might be appropriate for which situation.

Practical Takeaway: GLP-1 medications are approved for type 2 diabetes and weight management, with ongoing research into additional benefits. Understanding what conditions these medications have been studied for helps you have realistic conversations with your healthcare provider about whether one might be appropriate for you.

Potential Side Effects and Safety Considerations

Like all medications, GLP-1 receptor agonists can cause side effects. The most commonly reported side effects are gastrointestinal in nature. Nausea occurs in a significant percentage of people taking these medications, particularly when first starting or when doses increase. Vomiting, diarrhea, and constipation have also been reported. These side effects often decrease over time as your body adjusts to the medication, though they persist for some people.

The FDA has issued warnings about rare but serious side effects. Pancreatitis, which is inflammation of the pancreas, has been reported in people taking GLP-1 medications. Symptoms include severe pain in the upper abdomen, back pain, and nausea. Additionally, there have been reports of gallbladder problems, including gallstones, in people taking these medications. Thyroid concerns have also been documented, and these medications carry a warning about a potential risk of thyroid tumors in animal studies, though this has not been confirmed in human studies.

Vision changes have been reported by some people taking GLP-1 medications, particularly those with diabetes. Dehydration can occur because these medications reduce appetite and fluid intake, which can be serious if not managed carefully. Low blood sugar (hypoglycemia) can occur, particularly if you are also taking other diabetes medications like insulin.

Certain people may not be suitable candidates for GLP-1 medications. People with a personal or family history of medullary thyroid cancer should not take these medications. People with a history of severe allergic reactions to any component of the medication should avoid it. Pregnancy is a consideration, as these medications should generally not be used during pregnancy. People with certain kidney or liver conditions may need monitoring or dosage adjustments.

An informational guide about GLP-1 medications will include a comprehensive overview of reported side effects, how commonly they occur, when they typically appear, and what you can discuss with your healthcare provider about managing or monitoring for these effects. The guide emphasizes that your healthcare provider needs to know about all your medical conditions and other medications before prescribing a GLP-1 medication.

Practical Takeaway: Side effects are possible with GLP-1 medications, ranging from common gastrointestinal effects to rarer serious conditions. Discussing your complete medical history with your healthcare provider helps identify whether you have any risk factors that should influence the decision about whether to use one of these medications.

Cost, Insurance Coverage, and Affordability Options

GLP-1 medications are expensive. Without insurance, a month's supply of semaglutide or tirzepatide can cost between $900 and $1,300 or more, depending on the dosage and pharmacy. This puts these medications out of reach financially for many people, despite their potential health benefits. Understanding the cost landscape helps you plan and have informed discussions with your healthcare provider and insurance company.

Insurance coverage varies significantly. Medicare Part D covers some GLP-1 medications for type 2 diabetes management, but coverage restrictions may apply. Some plans require prior authorization, meaning your doctor must request permission from your insurance company before prescribing the medication. Others have step therapy requirements, which means you must try and potentially fail with other medications first. Many insurance plans do not cover GLP-1 medications for weight management, covering them only for diabetes treatment.

Medicaid coverage also varies by state. Some states cover GLP-1 medications for type 2 diabetes through Medicaid, while others do not. Weight management coverage through Medicaid is rare, though this is changing in some states. If you have Medicaid, you can contact your state's Medicaid office or your specific plan to understand what coverage may be available to you.

Pharmaceutical manufacturers offer patient assistance programs that may reduce costs for people who meet income requirements. Novo Nordisk, the manufacturer of semaglutide and liraglutide, offers a program that provides free medication to people with household incomes below certain